LIN is rated Sell at $493.16 versus the reconciled fair value midpoint of $276.69, implying -43.89% upside/downside. Confidence is separately disclosed at 87/100.
Bull: Accelerated transition to clean energy (hydrogen, carbon capture) drives higher-than-expected project backlogs. Sustained pricing power allows for continued operating margin expansion, while healthcare and electronics end-markets drive secular volume growth.
Cyclical Multiple Reversion: Market abruptly shifts pricing paradigm from 'secular compounder' to 'industrial cyclical', crushing the >25x multiple down to a historical 15x average.
LIN is rated Sell at $493.16 versus the reconciled fair value midpoint of $276.69, implying -43.89% upside/downside. Confidence is separately disclosed at 87/100.
Position sizing playbook →| Market cap | $228.0B | |
|---|---|---|
| Revenue (ttm) | 34.7B | |
| Net income (ttm) | 7.1B | |
| EPS (ttm) | $15.1 | |
| Shares out | 462.3M | |
| P/E (trailing) | 32.7x | |
| P/E (forward) | 25.0x | |
| Dividend | $6.40 (1.30%) | |
| Volume | 1,686,201 | |
| Beta | 0.74 | |
| Price target | $547 | +10.8% |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | — | $33.36B | $32.85B | $33.01B | $33.99B | +0.5% |
| Gross profit | — | $13.91B | $15.36B | $15.86B | $16.60B | +4.5% |
| Operating income | — | $6.46B | $8.11B | $8.60B | $9.25B | +9.4% |
| Net income | — | $4.15B | $6.20B | $6.57B | $6.90B | +13.6% |
| EPS (diluted) | $7.33 | $8.23 | $12.59 | $13.62 | $14.61 | +18.8% |
| EBITDA | — | $9.96B | $12.22B | $12.84B | $13.12B | +7.1% |
| R&D | — | $143.0M | $146.0M | $150.0M | $147.0M | +0.7% |
| SG&A | — | $3.11B | $3.30B | $3.34B | $3.43B | +2.5% |
| Model | Fair value (mid) | Weight |
|---|---|---|
| Forward earnings | $240 | 40% |
| FCFF DCF | $234 | 30% |
| Multi stage moat fade | $328 | 15% |
| Owner earnings | $492 | 10% |
| Peg adjusted peer | $237 | 5% |
| Reverse DCF | $0.00 | 0% |
Recent company headlines from major financial publishers.
Accelerated transition to clean energy (hydrogen, carbon capture) drives higher-than-expected project backlogs. Sustained pricing power allows for continued operating margin expansion, while healthcare and electronics end-markets drive secular volume growth.
Our baseline enforces a strict cyclical playbook, capping terminal multiples at 15x. Stable cash flows are recognized but heavily offset by necessary capital expenditures to maintain the highly localized industrial gas network.
A deep, prolonged global industrial recession severely impacts base volumes. Simultaneously, higher interest rates or persistent inflation constrain returns on newly deployed capital, limiting value creation from green energy transitions.
| Model | Weight | FV / share | vs spot | Contribution |
|---|---|---|---|---|
| Forward earnings | 40% | $240 | -51.2% | |
| FCFF DCF | 30% | $234 | -52.5% | |
| Multi stage moat fade | 15% | $328 | -33.4% | |
| Owner earnings | 10% | $492 | -0.3% | |
| Peg adjusted peer | 5% | $237 | -51.9% | |
| Reverse DCF | 0% | $0.00 | -100.0% | |
| Composite FV (weighted) | 100% | $277 | -43.9% |
| Ke ↓ / g → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 5.3% | $296 | $335 | $385 | $421 | $421 |
| 6.3% | $240 | $265 | $296 | $335 | $385 |
| 7.3% | $202 | $220 | $240 | $265 | $296 |
| 8.3% | $175 | $188 | $202 | $220 | $240 |
| 9.3% | $154 | $164 | $175 | $188 | $202 |
| Category | Weight | Score | Reading |
|---|---|---|---|
| Valuation | 11% | 5.0 | |
| Management | 11% | 6.9 | |
| Balance Sheet | 11% | 4.0 | |
| Profitability | 11% | 6.5 | |
| Revenue Growth | 11% | 6.0 | |
| Risk Assessment | 11% | 6.0 | |
| Competitive Moat | 11% | 9.0 | |
| Earnings Quality | 11% | 8.0 | |
| Capital Efficiency | 11% | 5.0 |
Upcoming earnings date and setup when available.